Published in Antimicrob Agents Chemother on March 24, 2017
Leishmaniasis worldwide and global estimates of its incidence. PLoS One (2012) 18.07
The lipophosphoglycan of Leishmania parasites. Annu Rev Microbiol (1992) 2.86
Combination therapy for visceral leishmaniasis. Lancet Infect Dis (2010) 1.96
Cutaneous Na+ storage strengthens the antimicrobial barrier function of the skin and boosts macrophage-driven host defense. Cell Metab (2015) 1.74
Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob Agents Chemother (2004) 1.63
Mitochondrial superoxide radicals mediate programmed cell death in Trypanosoma cruzi: cytoprotective action of mitochondrial iron superoxide dismutase overexpression. Biochem J (2007) 1.55
Permeation of bacterial cells, permeation of cytoplasmic and artificial membrane vesicles, and channel formation on lipid bilayers by peptide antibiotic AS-48. J Bacteriol (1991) 1.49
Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3,3'-diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani. Mol Pharmacol (2008) 1.48
Bactericidal and bacteriolytic action of peptide antibiotic AS-48 against gram-positive and gram-negative bacteria and other organisms. Res Microbiol (1989) 1.43
Peptide AS-48: prototype of a new class of cyclic bacteriocins. Curr Protein Pept Sci (2004) 1.29
Bacteriocin AS-48, a microbial cyclic polypeptide structurally and functionally related to mammalian NK-lysin. Proc Natl Acad Sci U S A (2000) 1.26
Antimycobacterial activity of bacteriocins and their complexes with liposomes. J Antimicrob Chemother (2007) 1.18
Lipid analyses of isolated surface membranes of Leishmania donovani promastigotes. Lipids (1985) 1.16
Miltefosine-induced apoptotic cell death on Leishmania major and L. tropica strains. Korean J Parasitol (2011) 1.01
Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis. Chem Rev (2014) 1.00
Developmental life cycle of Leishmania--cultivation and characterization of cultured extracellular amastigotes. J Eukaryot Microbiol (1993) 1.00
Preassembly of membrane-active peptides is an important factor in their selectivity toward target cells. Biochemistry (2002) 1.00
Effect of peptide AS-48 on Enterococcus faecalis subsp. liquefaciens S-47. Antimicrob Agents Chemother (1989) 0.99
Azurin, Plasmodium falciparum malaria and HIV/AIDS: inhibition of parasitic and viral growth by Azurin. Cell Cycle (2006) 0.99
Structure of bacteriocin AS-48: from soluble state to membrane bound state. J Mol Biol (2003) 0.99
Purification, characterization, and lytic activity against Naegleria fowleri of two amoebicins produced by Bacillus licheniformis A12. Appl Environ Microbiol (1993) 0.97
Amphibian antimicrobial peptides and Protozoa: lessons from parasites. Biochim Biophys Acta (2008) 0.97
Bacteriocins and their position in the next wave of conventional antibiotics. Int J Antimicrob Agents (2015) 0.97
Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody. Infect Immun (2002) 0.97
AS-48 bacteriocin: close to perfection. Cell Mol Life Sci (2011) 0.97
Antibacterial and antitumorigenic properties of microcin E492, a pore-forming bacteriocin. Curr Pharm Biotechnol (2009) 0.96
New benzophenone-derived bisphosphonium salts as leishmanicidal leads targeting mitochondria through inhibition of respiratory complex II. J Med Chem (2010) 0.95
A simple method for semi-preparative-scale production and recovery of enterocin AS-48 derived from Enterococcus faecalis subsp. liquefaciens A-48-32. J Microbiol Methods (2003) 0.93
An enhanced method for the identification of Leishmania spp. using real-time polymerase chain reaction and sequence analysis of the 7SL RNA gene region. Diagn Microbiol Infect Dis (2010) 0.93
Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria. Int J Antimicrob Agents (2010) 0.93
Artemisinin Action and Resistance in Plasmodium falciparum. Trends Parasitol (2016) 0.93
Antineoplastic properties of bacteriocins: revisiting potential active agents. Am J Clin Oncol (2008) 0.92
Effect of natural L- to D-amino acid conversion on the organization, membrane binding, and biological function of the antimicrobial peptides bombinins H. Biochemistry (2006) 0.90
Characterization of functional, safety, and probiotic properties of Enterococcus faecalis UGRA10, a new AS-48-producer strain. Food Microbiol (2011) 0.89
Influence of physico-chemical factors on the oligomerization and biological activity of bacteriocin AS-48. Curr Microbiol (2001) 0.89
Are bacteriocins underexploited? Novel applications for old antimicrobials. Curr Pharm Biotechnol (2011) 0.89
Mechanism Matters: A Taxonomy of Cell Penetrating Peptides. Trends Biochem Sci (2015) 0.89
Growing insights into the safety of bacteriocins: the case of enterocin S37. Res Microbiol (2010) 0.89
Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes. Mem Inst Oswaldo Cruz (2011) 0.88
Characterization of the leishmanicidal activity of antimicrobial peptides. Methods Mol Biol (2010) 0.86
An 'Upp'-turn in bacteriocin receptor identification. Mol Microbiol (2014) 0.85
Effect of bacterial metabolites on microsporidian Nosema ceranae and on its host Apis mellifera. Parasitol Res (2010) 0.85
Bacteriocins: Not Only Antibacterial Agents. Probiotics Antimicrob Proteins (2016) 0.85
Pinensins: the first antifungal lantibiotics. Angew Chem Int Ed Engl (2015) 0.85
Bacteriocin AS-48 binding to model membranes and pore formation as revealed by coarse-grained simulations. Biochim Biophys Acta (2013) 0.85
Antimicrobial peptide action on parasites. Curr Drug Targets (2012) 0.84
Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment. Clin Microbiol Rev (2014) 0.83
The Cyclic Antibacterial Peptide Enterocin AS-48: Isolation, Mode of Action, and Possible Food Applications. Int J Mol Sci (2014) 0.82
Bacteriocins from lactic acid bacteria and their applications in meat and meat products. Meat Sci (2016) 0.81
The plasma membrane electrical gradient (membrane potential) in Leishmania donovani promastigotes and amastigotes. Mol Biochem Parasitol (1992) 0.81
Fatty acid composition modulates sensitivity of Legionella pneumophila to warnericin RK, an antimicrobial peptide. Biochim Biophys Acta (2010) 0.81
Enhanced leishmanicidal activity of cryptopeptide chimeras from the active N1 domain of bovine lactoferrin. Amino Acids (2012) 0.81
Bacteriocins as Potential Anticancer Agents. Front Pharmacol (2015) 0.80
Potential Applications of the Cyclic Peptide Enterocin AS-48 in the Preservation of Vegetable Foods and Beverages. Probiotics Antimicrob Proteins (2010) 0.79
Therapeutic enhancement of newly derived bacteriocins against Giardia lamblia. Exp Parasitol (2014) 0.79
Molecular mechanisms of membrane targeting antibiotics. Biochim Biophys Acta (2015) 0.79
The induction of NOS2 expression by the hybrid cecropin A-melittin antibiotic peptide CA(1-8)M(1-18) in the monocytic line RAW 264.7 is triggered by a temporary and reversible plasma membrane permeation. Biochim Biophys Acta (2005) 0.79
Monolayer Characteristics of Bacteriocin AS-48, pH Effect and Interactions with Dipalmitoyl Phosphatidic Acid at the Air-Water Interface. J Colloid Interface Sci (2001) 0.78
A peptide factor secreted by Staphylococcus pseudintermedius exhibits properties of both bacteriocins and virulence factors. Sci Rep (2015) 0.78
Trends in utilization of agro-industrial byproducts for production of bacteriocins and their biopreservative applications. Crit Rev Biotechnol (2014) 0.78
Total Synthesis of Circular Bacteriocins by Butelase 1. J Am Chem Soc (2016) 0.77
Antifungal properties of durancins isolated from Enterococcus durans A5-11 and of its synthetic fragments. Lett Appl Microbiol (2013) 0.77
Anti-Candida activity of two-peptide bacteriocins, plantaricins (Pln E/F and J/K) and their mode of action. Fungal Biol (2014) 0.77
Potentiated anti-microsporidial activity of Lactobacillus acidophilus CH1 bacteriocin using gold nanoparticles. Exp Parasitol (2014) 0.77
The bacteriocin AS-48 requires dimer dissociation followed by hydrophobic interactions with the membrane for antibacterial activity. J Struct Biol (2015) 0.77
Microcin J25-Ga induces apoptosis in mammalian cells by inhibiting mitochondrial RNA-polymerase. Peptides (2011) 0.76
Antimicrobial Peptides and their Pore/Ion Channel Properties in Neutralization of Pathogenic Microbes. Curr Top Med Chem (2016) 0.76
Neutralizing antibodies against the peptide antibiotic AS-48: immunocytological studies. Antimicrob Agents Chemother (1993) 0.76
Introduction: drug discovery and development for neglected diseases. Chem Rev (2014) 0.76
Alice in microbes' land: adaptations and counter-adaptations of vector-borne parasitic protozoa and their hosts. FEMS Microbiol Rev (2016) 0.76
Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective. Drug Discov Today (2016) 0.76
Analysis of the promoters involved in enterocin AS-48 expression. PLoS One (2014) 0.78